Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world… Read more
HEOR Feature
Featured
France’s New Pricing Rules Increase Access to Orphan Drugs
A March 2021 agreement between the Frrench Ministry of Health and the French Pharmaceutical Companies Association has reduced barriers to access to… Read more
Interview with Tobias Polak: Gleaning Real-World Data from Expanded Access Programs
Tobias Polak, a PhD student at Erasmus University and Director of Real-World Data (RWD) myTomorrows, recently published a paper in the British Journal… Read more
Real-World Data Study Shows that Biologics are Widely Used and Effective for Severe Asthma
A new real-world data (RWD) study published in the Annals of Allergy, Asthma & Immunology shows that biologics are both commonly used and very… Read more
The Latest Blogs from tHEORetically Speaking
- What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian?
- Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments
- Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?
- The Belgium reimbursement pathway for digital health applications is similarly easy as in Germany, correct Katrien de Groote?
- Boston Strategic Partners Supplier Spotlight
